Acute pharmacological degradation of ERK5 does not inhibit cellular immune response or proliferation
Inchul You, Katherine A. Donovan, Noah M. Krupnick, Andrew S. Boghossian, Matthew G. Rees, Melissa M. Ronan, Jennifer A. Roth, Eric S. Fischer, Eric S. Wang, Nathanael S. Gray
Topics & Concepts
Gene knockdownPhenotypeKinaseCancer researchImmune systemBiologyCell biologyInflammationCell growthSignal transductionComputational biologyCell cultureImmunologyGeneGeneticsProtein Degradation and InhibitorsMelanoma and MAPK PathwaysUbiquitin and proteasome pathways